Related Experiment Videos
Low-dose dopamine: a systematic review.
1Anesthesiology and Critical Care, Department of Critical Care Medicine, University of Pittsburgh Medical Center, 640A Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA. maripe@ccm.upmc.edu
Intensive Care Medicine
|July 18, 2002
Summary
Low-dose dopamine does not protect kidneys in patients with early renal injury. This meta-analysis found no significant benefit in preventing acute kidney dysfunction, suggesting it should not be used for renal protection.
Area of Science:
- Nephrology
- Pharmacology
- Critical Care Medicine
Background:
- Acute kidney injury (AKI) is a common complication in critically ill patients.
- Low-dose dopamine has been proposed as a renal-protective agent.
- Evidence supporting its efficacy remains controversial.
Purpose of the Study:
- To evaluate the effectiveness of low-dose dopamine in preserving renal function.
- To determine if low-dose dopamine reduces the incidence of acute renal dysfunction.
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials.
- Included studies compared low-dose dopamine with placebo in patients at risk for or with early renal injury.
- Data from 15 studies involving 970 patients were analyzed.
Main Results:
- Low-dose dopamine did not significantly alter serum creatinine levels (mean difference 5.1 micromol/l).
- The incidence of acute renal dysfunction was similar between dopamine and placebo groups (31% vs 33%).
- No specific patient subgroup demonstrated a renal benefit from low-dose dopamine.
Conclusions:
- This meta-analysis confirms that low-dose dopamine lacks a reno-protective effect.
- Given potential adverse effects, low-dose dopamine is not recommended for preventing or treating renal dysfunction.